Professional
Added to YB: 2024-07-18
Pitch date: 2024-07-12
TMDX [bullish]
TransMedics Group, Inc.
-14.66%
current return
Author Info
No bio for this author
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.5B
Pitch Price
$144.31
Price Target
N/A
Dividend
N/A
EV/EBITDA
35.52
P/E
51.63
EV/Sales
7.99
Sector
Health Care Equipment and Supplies
Category
growth
Headwaters Capital Portfolio Holding: TransMedics Group, Inc.
TMDX +104% on strong Q1, raised guidance. Internal logistics fleet driving adoption of organ care system. Low market penetration in liver, heart, lung transplants. Potential for long-term revenue growth due to market expansion and increased adoption. Revolutionary technology poised for multi-year growth trajectory.
Read full article (1 min)